The results of the centralized procurement of Class 1 consumables have been announced! One hundred enterprises were shortlisted, with domestic products accounting for over 90%

The centralized procurement of another type of consumables in Guangdong has been confirmed.

The winning results of the follow-up procurement of disposable laparoscopic puncture devices have been officially announced, with 100 enterprises successfully breaking through

Without further ado, let's get straight to the core information

Here's the key point: The lowest winning price is 26 yuan and the highest is 1,148 yuan. Among the 323 selected products, only 22 are imported, while domestic ones dominate the screen! The procurement cycle was directly set to June 2028, remaining stable for over three years

01 100 enterprises have landed! The selected list contains these key pieces of information

Recently, the Guangdong Provincial Pharmaceutical Exchange Center officially released the list. This time, it is the follow-up procurement of "disposable laparoscopic puncture devices". After all, the notice of continued procurement was issued in June before, and people in the industry have been waiting for this result for a long time.。

First, let's clarify the scope of procurement

• Products with the first ten digits of the code being C160401026 and C160402026 (single-hole multi-channel ones are not included)

• Covering all public hospitals in Guangdong Province, including military hospitals

Compared with the list of proposed winners on October 31st, the official results have 6 fewer products and 4 fewer enterprises, but the core price range remains unchanged:

•Floor price: 26 yuan: Disposable cannula puncture device from Changzhou Huankang (both single and set prices are this price)

•Ceiling price of 1,148 yuan: The fascia suture puncture device from Hainan Lili Sheng, the puncture type suture device from Jiangsu Fenghe, and the valveless puncture device with filter from Shide (Changsha) (all are selected limited edition products)

What domestic medical device enterprises can be most proud of is that among the 323 selected products, 301 are domestic and only 22 are imported. Moreover, the prices of imported products range from 250 to 980 yuan, and the cost-performance advantage of domestic products is directly maximized.

02 Guangdong's centralized procurement has been implemented intensively! Why is this consumable a frequent guest in centralized procurement?

Recently, the pace of centralized procurement in Guangdong has been visibly fast.

Apart from the puncture device this time, among the three types of consumables that were previously notified for follow-up procurement, the cardiac pacemaker and the tubular end stapler/hemorrhoid stapler have been officially implemented on December 1st. Now, the disposable laparoscopic puncture device is also following suit. The three types of consumables are gradually being implemented, and the hospital's procurement costs will drop further

Some people may ask: Why are laparoscopic puncture devices always on the list of centralized procurement?

The answer is simple: large volume and stable market.

As a "must-have consumable" for laparoscopic surgery, the market size has been increasing in recent years. Frost & Sullivan predicts that the Chinese market could reach 2.99 billion yuan by 2025.

Moreover, the domestic production rate is extremely high: Among the 133 products currently on the market, the top 10 are all domestic enterprises, with only Weizhi (Suzhou) temporarily ranking first with 3 products. The number of products among each enterprise is not significantly different, and the competition is quite fierce.

More importantly, it is a collection of familiar faces. Data shows that it has accumulated a total of 13,557 pieces of centralized procurement information.

Guangdong is the "top province" for centralized procurement of such products, with a higher procurement frequency than provinces like Jiangxi and Yunnan. This year, the inter-city alliance of Zhuzhou, Hunan and the Beijing-Tianjin-Hebei alliance have also caught up, making it a key category for national centralized procurement without any problem.

03 Must-read for Insiders: Centralized procurement is no longer about competing on low prices

Finally, let's talk about a few industry trends: In recent years, centralized procurement has been advancing layer by layer from inter-provincial alliances to provincial and municipal levels. Whether it's high-value or low-value consumables, the price water has indeed been squeezed out almost completely.

Previously, people were afraid of "price cuts due to internal competition", but now it is obvious that the extent of price cuts is getting more and more moderate, and the voices against "internal competition" are also getting louder and louder.

Obviously, in the future, centralized procurement will not merely focus on who offers the lowest price. The "value index" of product quality and clinical adaptability will become increasingly important. In other words, shifting from a "price war" to a "value war" is the true way for medical device enterprises to survive.